Question special
Lead Moderator

To put adnexanet in context further, there is an antibody fragment, idarucizumab, that has been shown in a prospective cohort study to reverse the anticoagulant effect of dabigatran. This agent is specific to dabigatran, but it would be informative to compare/discuss the mechanism of action to that of adnexanet.